About 4 300 reports

Global Acute Coronary Syndrome (ACS) Market 2015-2019

97 pages • By Infiniti Research Limited

About ACSACS is a condition that results in sudden and reduced blood flow to the heart. ACS is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and short-term mortality. On the basis of evidence of heart muscle damage and changes in the ST-tracing of the ECG, ACS is classified...

2 000 2 500 1 600
Mar 2015

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

102 pages • By Infiniti Research Limited

About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause of small cell lung cancer, though it also occurs in non-smokers. Lung cancer...

2 400 3 000 1 920
Mar 2015

Global Osteoarthritis Market 2015-2019

93 pages • By Infiniti Research Limited

About OAOA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is not fully understood. Obesity, overuse of the joint, weak thigh muscles, aging, and genetics are some of the common risk factors of OA;...

2 000 2 500 1 600
Mar 2015

HER-2 Positive Breast Cancer Market in the US 2015-2019

108 pages • By Infiniti Research Limited

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated...

2 400 3 000 1 920
Mar 2015

Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019

103 pages • By Infiniti Research Limited

About According to WHO, CKD is not only common, treatable, and harmful but also a major contributing factor to the incidence and outcomes of at least three of the diseases that are targeted by WHO (hypertension, diabetes, and CVD). CKD is mainly defined as a reduced GFR, increased urinary albumin excretion, or both, and is growing public...

2 400 3 000 1 920
Mar 2015

Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

114 pages • By Infiniti Research Limited

About Acquired Orphan Blood Diseases TherapeuticsAcquired orphan blood diseases are rare disorders and are characterized by the body's inability to produce a sufficient amount of RBCs. This is basically because of the improper functioning of bone marrow to produce RBCs in the blood. This leads to a decrease in platelet counts, which can...

2 400 3 000 1 920
Mar 2015

Western and Eastern European Custom Procedure Trays and Packs (CPTP) Market : Ripe Opportunities Exist Within the Growing Landscape

50 pages • By Frost & Sullivan

Methodology•Primary interviews were conducted with key industry experts and regulatory authorities. Designations of interviewed participants include chief executive officers, marketing managers, directors, and vice presidents.•Secondary research sources such as in-house Frost & Sullivan database, Frost & Sullivan’s Decision...

4 800 6 000 3 840
Mar 2015

Market Understanding for Diabetes Management Programs

54 pages • By VBI Solution

1. Key Demand Centers– Top 5 Cities in India - Prevalence: Key Demand Centers2. Key Player Profiles2.1 Competitive Mapping - Overview - Competitive Mapping: Overview2.2 Dr. Mohan Diabetes Specialties Center (DMDSC) - DMDSC: Patient Flow - DMDSC: Departments - DMDSC: Instrumentation used - DMDSC: Team...

784 980 627
Mar 2015

Market Assessment of Anti-diarrheal drugs in Turkey

119 pages • By VBI Solution

Diarrhea in Turkey - The incidence of diarrhea is in the range of 17-18% ofthe Turkish population. The key causative factors for`the incidence are the unhygienic living conditions and unclean drinking water. - Diarrheal incidence in the country is observed to be relatively higher in in pediatric age group, with majority of the...

2 320 2 900 1 856
Mar 2015

Cardiometabolic Drug News MARCH 2015

15 pages • By Espicom Business Intelligence

Industry Trend Analysis - Sanofi's Lantus Successor Will See EC Approval And US Launch In Q215Industry Brief - Amarin/Eddingpharm Enter Agreement For Vascepa In ChinaIndustry Brief - Islet/BHV Enter Exclusive Licence Agreement For Phase II SGLT2 InhibitorIndustry Brief - Laguna Completes Series B Financing; Appoints CEOIndustry...

825 1 114 685
Mar 2015

CNS Drug News 02 MARCH 2015

20 pages • By Espicom Business Intelligence

Industry Trend Analysis - UK Government To Invest In Dementia ResearchIndustry Trend Analysis - Xadago's Approval Will Not Address Need For Disease-Modifying Parkinson's DrugsIndustry Brief - Biotie To Conduct Tozadenant Phase III Study In PDIndustry Brief - Eisai's Aricept NDA For Severe AD Accepted For Review In ChinaIndustry...

825 1 114 685
Mar 2015

Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019

76 pages • By Infiniti Research Limited

About Sleep Apnea Diagnostic and Therapeutic DevicesSleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches,...

2 000 2 500 1 600
Mar 2015

Global HER-2 Positive Breast Cancer Market 2015-2019

123 pages • By Infiniti Research Limited

About HER-2 Positive Breast CancerBreast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated...

2 400 3 000 1 920
Mar 2015

Stroke Diagnostics and Therapeutics: Global Markets

161 pages • By BCC Research

REPORT HIGHLIGHTSThe global stroke management market was valued at $19.2 billion in 2013 and nearly $20.2 billion in 2014. This market is expected to reach nearly $28.3 billion by 2019, with a compound annual growth rate (CAGR) of 7% from 2014 to 2019.This report provides:An overview of the global market...

5 320 6 650 4 256
Mar 2015

Pancreatic Cancer Partnering 2010-2015

150 pages • By Currentpartnering

The Pancreatic cancer Partnering 2010-2015 report provides understanding and access to the pancreatic cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in pancreatic cancer partnering dealsTop pancreatic cancer deals by valueDeals listed by company A-Z, industry sector, stage...

796 995 637
Mar 2015

Acne Partnering 2010-2015

100 pages • By Currentpartnering

The Acne Partnering 2010-2015 report provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in acne partnering dealsTop acne deals by valueDeals listed by company A-Z, industry sector, stage of development, technology type The Acne...

636 795 509
Mar 2015

Migraine Partnering 2010-2015

150 pages • By Currentpartnering

The Migraine Partnering 2010-2015 report provides understanding and access to the migraine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in migraine partnering dealsTop migraine deals by valueDeals listed by company A-Z, industry sector, stage of development, technology type...

636 795 509
Mar 2015

Epilepsy Partnering 2010-2015

150 pages • By Currentpartnering

The Epilepsy Partnering 2010-2015 report provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in epilepsy partnering dealsTop epilepsy deals by valueDeals listed by company A-Z, industry sector, stage of development, technology type...

636 795 509
Mar 2015

Parkinson%s Disease Partnering 2010-2015

150 pages • By Currentpartnering

The Parkinson’s Disease Partnering 2010-2015 report provides understanding and access to the parkinson’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in parkinson’s disease partnering dealsTop parkinson’s disease deals by valueDeals listed by company A-Z, industry sector,...

796 995 637
Mar 2015

Multiple Sclerosis Partnering 2010-2015

150 pages • By Currentpartnering

The Multiple Sclerosis Partnering 2010-2015 report provides understanding and access to the multiple sclerosis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in multiple sclerosis partnering dealsTop multiple sclerosis deals by valueDeals listed by company A-Z, industry sector,...

796 995 637
Mar 2015

Myocardial Infarction Partnering 2010-2015

100 pages • By Currentpartnering

The Myocardial Infarction Partnering 2010-2015 report provides understanding and access to the myocardial infarction partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in myocardial infarction partnering dealsTop myocardial infarction deals by valueDeals listed by company A-Z, industry...

636 795 509
Mar 2015

Hypertension Partnering 2010-2015

100 pages • By Currentpartnering

The Hypertension Partnering 2010-2015 report provides understanding and access to the hypertension partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hypertension partnering dealsTop hypertension deals by valueDeals listed by company A-Z, industry sector, stage of development,...

636 795 509
Mar 2015

Coronary Artery Disease Partnering 2010-2015

100 pages • By Currentpartnering

The Coronary Artery Disease Partnering 2010-2015 report provides understanding and access to the coronary artery disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in coronary artery disease partnering dealsTop coronary artery disease deals by valueDeals listed by company...

636 795 509
Mar 2015

Atherosclerosis Partnering 2010-2015

100 pages • By Currentpartnering

The Atherosclerosis Partnering 2010-2015 report provides understanding and access to the atherosclerosis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in atherosclerosis partnering dealsTop atherosclerosis deals by valueDeals listed by company A-Z, industry sector, stage of...

636 795 509
Mar 2015

Congestive Heart Failure Partnering 2010-2015

100 pages • By Currentpartnering

The Congestive Heart Failure Partnering 2010-2015 report provides understanding and access to the congestive heart failure partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in congestive heart failure partnering dealsTop congestive heart failure deals by valueDeals listed by company...

636 795 509
Mar 2015

Hypercholesterolemia Partnering 2010-2015

100 pages • By Currentpartnering

The Hypercholesterolemia Partnering 2010-2015 report provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hypercholesterolemia partnering dealsTop hypercholesterolemia deals by valueDeals listed by company A-Z, industry...

636 795 509
Mar 2015

Arrhythmia Partnering 2010-2015

100 pages • By Currentpartnering

The Arrhythmia Partnering 2010-2015 report provides understanding and access to the arrhythmia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in arrhythmia partnering dealsTop arrhythmia deals by valueDeals listed by company A-Z, industry sector, stage of development, technology...

636 795 509
Mar 2015

Traumatic Brain Injury Partnering 2010-2015

100 pages • By Currentpartnering

The Traumatic Brain Injury Partnering 2010-2015 report provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in traumatic brain injury partnering dealsTop traumatic brain injury deals by valueDeals listed by company A-Z,...

636 795 509
Mar 2015

Stroke Partnering 2010-2015

150 pages • By Currentpartnering

The Stroke Partnering 2010-2015 report provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in stroke partnering dealsTop stroke deals by valueDeals listed by company A-Z, industry sector, stage of development, technology type The...

636 795 509
Mar 2015

Dermatitis Partnering 2010-2015

100 pages • By Currentpartnering

The Dermatitis Partnering 2010-2015 report provides understanding and access to the dermatitis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dermatitis partnering dealsTop dermatitis deals by valueDeals listed by company A-Z, industry sector, stage of development, technology...

636 795 509
Mar 2015